Global Digital Diabetes Management Market Assessment, By Products and Services [Devices, Data Management Software and Platform, Diabetes Applications, Services], By Device Type [Handheld Devices, Wearable Devices], By Patient Type [Type 1 Diabetes, Type 2 Diabetes], By End-user [Home Healthcare, Hospitals and Specialty Clinics, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
Global digital diabetes management market is projected to witness a CAGR of 11.47% during the forecast period 2024-2031F, growing from USD 18.36 billion in 2023 to USD 43.76 billion in 2031F.
Home>Industry Reports>Global Digital Diabetes Management Market Assessment, Opportunities, and Forecast, 2017-2031F
Global digital diabetes management market is projected to witness a CAGR of 11.47% during the forecast period 2024-2031F, growing from USD 18.36 billion in 2023 to USD 43.76 billion in 2031F. The market’s growth is bolstered by the rising cases of diabetes, increasing emphasis on disease surveillance, growing popularity of remote patient monitoring, rising investments towards novel product development, and increasing collaborations between the key players of the market.
The rapid adoption of digital diabetes management products and services can also be attributed to the ease of use associated with them. They allow for communication between physicians and patients on a regular basis and the constant monitoring of the glycemic data allows healthcare professionals and caretakers to improve health outcomes by enhancing the quality of care provided to the patients.
Additionally, the introduction of novel technologies by various companies bolsters the global digital diabetes management market size. In August 2023, Welldoc Platform announced that they had received 510 (k) FDA clearance for their BlueStar digital diabetes management platform. This clearance allowed BlueStar to ensure that the bolus insulin dose was provided as per the recommendations on the basis of the continuous glucose readings. This development is expected to aid patients who require multiple injections of insulin on a daily basis to manage diabetes. Additionally, in July 2023, Better Therapeutics, Inc. also received authorization from the Food and Drug Administration for AspyreRx, a prescription-only digital therapeutic treatment used for providing cognitive behavioral therapy to patients suffering from type 2 diabetes who are 18 or older. Such developments and approvals are expected to boost the global digital diabetes management market demand and provide lucrative growth opportunities to the market.
Increasing Governmental Efforts Support Market Expansion
The growing burden of diabetes and the increasing requirement for advanced digital solutions that allow the management of the condition in a streamlined manner are some of the major factors because of which various governments are investing in digital tools and services for managing diabetes. In 2023, the government of South Korea launched the Nation Integrated Bio-big Data Project to collect data from the participants to understand the new trends and implement effective measures to enhance patient outcomes. Additionally, in 2021 the Government of Canada announced an investment of USD 35 million in diabetes prevention, of which USD 25 million were promised for the development of a national framework for diabetes as well as towards research and surveillance. Such initiatives and supportive measures are expected to support the expansion of the market and boost the demand for digital diabetes management products and services.
Rising Cases of Diabetes Bolster Market Demand
The rise in the number of cases of diabetes in various regions across the globe due to increasing obesity, genetics, and sedentary lifestyles is propelling the requirement for digital diabetes management devices and services. According to the estimates of the World Health Organization (WHO), approximately 422 million individuals across the globe are living with diabetes. This increase is augmenting the efforts of various healthcare companies and academic institutions towards the development of digital diabetes management products as the self-monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM), mHealth apps, and decision support systems aid in reducing glycemic variability, HbA1c levels, and enhance self-management of diabetes to ensure timely interventions in case of hypoglycemic events. The data collected from digital diabetes management devices have the potential of detecting hypoglycemia and ensures the safety and efficacy of digital support systems and workflow, thus boosting the market’s expansion.
North America Accounts for Significant Market Share
The growth of the market in North America is supported by the rising cases of diabetes in the region, strong presence of key market players, and high acceptance of novel digital disease management solutions. Digital diabetes management devices aid healthcare providers in visualizing trends in blood glucose levels, generating reports, analyzing collected data, and ensuring medication adherence. Due to the rising cases of diabetes in the region, the reliance on digital devices and services has significantly increased to ensure optimal care is provided to the patients and allow the effective management of the disease. According to the estimates of the US Centers for Disease Control and Prevention, in 2021 approximately 29.7 million individuals, accounting for 8.9% of the population of the United States, had been diagnosed with diabetes.
The increasing accessibility of digital diabetes management services and products coupled with the rising efforts of the companies based in the regions towards the development of novel solutions is further propelling the expansion of the market in North America. In October 2023, Insulet Corporation announced that their Omnipod 5 App for iPhone has received 510 (k) clearance from the FDA. With this clearance, Insulet became the first company known for offering automated insulin delivery systems that are compatible with iOS and Android smartphones. Such developments are expected to boost the accessibility of digital diabetes management solutions, augmenting the expansion of the market in the region.
Wearable Devices Expected to Account Significant Share of the Market
The growth of the segment can be attributed to the different advantages associated with their usage, including automated insulin delivery and the availability of real-time insights related to blood glucose levels. Additionally, artificial intelligence (AI) tools and advanced analytics can also aid healthcare professionals in predicting blood glucose fluctuations and analyzing data, allowing them to suggest personalized treatment options and determine various risk factors and complications associated with diabetes.
Furthermore, the continuous efforts of various health technology companies towards the development of wearable devices with advanced technologies is another major factor supporting the expansion of the segment. In March 2024, Dexcom, Inc. received clearance from the US Food and Drug Administration for Stelo. This wearable glucose biosensor is worn by the patients on the back of their arms and delivers data directly on their smartphones. With the help of constant health monitoring and wearable devices, valuable insights are provided to physicians and patients to facilitate preventive measures and early interventions for potential chronic situations.
Future Market Scenario (2024-2031F)
According to the global digital diabetes management market analysis, the growing popularity of remote patient monitoring and increased acceptance of digital devices for the management of various diseases and disorders is anticipated to provide lucrative growth opportunities to the market. The rising cases of diabetes are also expected to bolster the market demand. According to the estimates of The Lancet, approximately 1.3 billion individuals are expected to have diabetes by 2050.
Personalization of healthcare with the help of digital devices is also expected to improve patient access to different treatments and allow them to effectively manage long-term diseases such as diabetes. Additionally, with the help of data analysis, digital diabetes management solutions are expected to aid in enhancing the understanding of the requirements of the patients as well as strengthen partnerships with digital experts. Furthermore, AI is expected to play a crucial role in providing personalized diabetes management by analyzing the glucose data of millions of individuals round-the-clock, which in turn can support decision-making for individual patients and ensure that they are provided with recommendations suggested to their requirements. Thus, boosting the expansion of the market in the coming years.
Report Scope
“Digital Diabetes Management Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global digital diabetes management market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 11.47% between 2024-2031F |
|
Revenue Forecast in 2031 |
USD 43.76 billion |
|
Segments Covered |
Products and Services, Device Type, Patient Type, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profiled |
Dexcom, Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic, B. Braun SE, Tandem Diabetes Care, Inc., LifeScan, Inc., Insulet Corporation, Bayer AG, Ascensia Diabetes Care Holdings AG |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global digital diabetes management market has been segmented into the following categories:
· By Products and Services
o Devices
§ Smart Insulin Pens
§ Smart Glucose Meters
§ Smart Insulin Pumps
§ Continuous Blood Glucose Monitoring (CGM) System
o Data Management Software and Platform
o Diabetes Applications
§ Obesity and Diet Management Apps
§ Diabetes and Blood Glucose Tracking Apps
o Services
· By Device Type
o Handheld Devices
o Wearable Devices
· By Patient Type
o Type 1 Diabetes
o Type 2 Diabetes
· By End-user
o Home Healthcare
o Hospitals and Specialty Clinics
o Academic and Research Institutes
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
The rising collaborations between key players of the market to boost the development and introduction of novel products and technologies in different geographical locations is supporting the global digital diabetes management market growth. In July 2024, Abbott and Dexcom announced that they will be launching their continuous glucose monitor in the coming months of 2024. The devices are expected to aid the companies in reaching approximately 25 million individuals in the United States that are suffering from Type 2 diabetes and do not take insulin, 85 million with undiagnosed pre-diabetes, and 15 million with pre-diabetes.
In March 2023, Roche Diabetes Care Japan Co., Ltd. and Astellas Pharma Inc. announced that they had entered in an agreement to commercialize and develop Roche’s Accu-Chek Guide Me blood glucose monitoring system. The development of advanced digital solutions for management of diabetes is gaining traction in Japan due to the rising cases of the disease in the country, thus supporting the growth of the market.
Key Players Operating in the Global Digital Diabetes Management Market are:
· F. Hoffmann-La Roche Ltd
· Abbott Laboratories
· Medtronic
· B. Braun SE
· Tandem Diabetes Care, Inc.
· LifeScan, Inc.
· Insulet Corporation
· Bayer AG
· Ascensia Diabetes Care Holdings AG
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global digital diabetes management market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Digital Diabetes Management Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Products and Services
4.2.1.Devices
4.2.1.1. Smart Insulin Pens
4.2.1.2. Smart Glucose Meters
4.2.1.3. Smart Insulin Pumps
4.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
4.2.2.Data Management Software and Platform
4.2.3.Diabetes Applications
4.2.3.1. Obesity and Diet Management Apps
4.2.3.2. Diabetes and Blood Glucose Tracking Apps
4.2.4.Services
4.3. By Device Type
4.3.1.Handheld Devices
4.3.2.Wearable Devices
4.4. By Patient Type
4.4.1.Type 1 Diabetes
4.4.2.Type 2 Diabetes
4.5. By End-user
4.5.1.Home Healthcare
4.5.2.Hospitals and Specialty Clinics
4.5.3.Academic and Research Institutes
4.5.4.Others
4.6. By Region
4.6.1.North America
4.6.2.South America
4.6.3.Europe
4.6.4.Asia-Pacific
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global Digital Diabetes Management Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Products and Services
5.1.2.1. Devices
5.1.2.1.1. Smart Insulin Pens
5.1.2.1.2. Smart Glucose Meters
5.1.2.1.3. Smart Insulin Pumps
5.1.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
5.1.2.2. Data Management Software and Platform
5.1.2.3. Diabetes Applications
5.1.2.3.1. Obesity and Diet Management Apps
5.1.2.3.2. Diabetes and Blood Glucose Tracking Apps
5.1.2.4. Services
5.1.3.By Device Type
5.1.3.1. Handheld Devices
5.1.3.2. Wearable Devices
5.1.4.By Patient Type
5.1.4.1. Type 1 Diabetes
5.1.4.2. Type 2 Diabetes
5.1.5.By End-user
5.1.5.1. Home Healthcare
5.1.5.2. Hospitals and Specialty Clinics
5.1.5.3. Academic and Research Institutes
5.1.5.4. Others
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.1.2. By Volume
5.1.6.2. By Products and Services
5.1.6.2.1. Devices
5.1.6.2.1.1. Smart Insulin Pens
5.1.6.2.1.2. Smart Glucose Meters
5.1.6.2.1.3. Smart Insulin Pumps
5.1.6.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
5.1.6.2.2. Data Management Software and Platform
5.1.6.2.3. Diabetes Applications
5.1.6.2.3.1. Obesity and Diet Management Apps
5.1.6.2.3.2. Diabetes and Blood Glucose Tracking Apps
5.1.6.2.4. Services
5.1.6.3. By Device Type
5.1.6.3.1. Handheld Devices
5.1.6.3.2. Wearable Devices
5.1.6.4. By Patient Type
5.1.6.4.1. Type 1 Diabetes
5.1.6.4.2. Type 2 Diabetes
5.1.6.5. By End-user
5.1.6.5.1. Home Healthcare
5.1.6.5.2. Hospitals and Specialty Clinics
5.1.6.5.3. Academic and Research Institutes
5.1.6.5.4. Others
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East and Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Products and Services
6.2. By Device Type
6.3. By Patient Type
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat From New Entrants
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Dexcom, Inc.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products and Services
13.1.4. Financials (As Reported)
13.1.5. Key Market Focus and Geographical Presence
13.1.6. Recent Developments
13.2. F. Hoffmann-La Roche Ltd
13.3. Abbott Laboratories
13.4. Medtronic
13.5. B. Braun SE
13.6. Tandem Diabetes Care, Inc.
13.7. LifeScan, Inc.
13.8. Insulet Corporation
13.9. Bayer AG
13.10. Ascensia Diabetes Care Holdings AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 4. Global Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 5. Global Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 6. Global Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 7. Global Digital Diabetes Management Market Share (%), By Region, 2017-2031F
Figure 8. North America Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 10. North America Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 11. North America Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 12. North America Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 13. North America Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 14. North America Digital Diabetes Management Market Share (%), By Country, 2017-2031F
Figure 15. United States Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 17. United States Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 18. United States Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 19. United States Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 20. United States Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 23. Canada Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 24. Canada Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 25. Canada Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 26. Canada Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 29. Mexico Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 30. Mexico Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 31. Mexico Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 32. Mexico Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 35. Europe Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 36. Europe Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 37. Europe Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 38. Europe Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Digital Diabetes Management Market Share (%), By Country, 2017-2031F
Figure 40. Germany Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 42. Germany Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 43. Germany Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 44. Germany Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 45. Germany Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 46. France Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 48. France Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 49. France Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 50. France Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 51. France Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 54. Italy Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 55. Italy Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 56. Italy Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 57. Italy Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 60. United Kingdom Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 61. United Kingdom Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 62. United Kingdom Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 63. United Kingdom Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 66. Russia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 67. Russia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 68. Russia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 69. Russia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 72. Netherlands Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 73. Netherlands Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 74. Netherlands Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 75. Netherlands Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 78. Spain Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 79. Spain Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 80. Spain Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 81. Spain Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 84. Turkey Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 85. Turkey Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 86. Turkey Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 87. Turkey Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 90. Poland Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 91. Poland Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 92. Poland Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 93. Poland Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 94. South America Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 96. South America Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 97. South America Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 98. South America Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 99. South America Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 100. South America Digital Diabetes Management Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 103. Brazil Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 104. Brazil Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 105. Brazil Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 106. Brazil Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 109. Argentina Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 110. Argentina Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 111. Argentina Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 112. Argentina Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 115. Asia-Pacific Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 116. Asia-Pacific Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 117. Asia-Pacific Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 118. Asia-Pacific Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Digital Diabetes Management Market Share (%), By Country, 2017-2031F
Figure 120. India Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 122. India Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 123. India Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 124. India Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 125. India Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 126. China Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 128. China Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 129. China Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 130. China Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 131. China Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 134. Japan Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 135. Japan Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 136. Japan Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 137. Japan Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 140. Australia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 141. Australia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 142. Australia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 143. Australia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 146. Vietnam Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 147. Vietnam Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 148. Vietnam Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 149. Vietnam Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 152. South Korea Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 153. South Korea Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 154. South Korea Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 155. South Korea Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 158. Indonesia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 159. Indonesia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 160. Indonesia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 161. Indonesia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 164. Philippines Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 165. Philippines Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 166. Philippines Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 167. Philippines Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 170. Middle East & Africa Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 171. Middle East & Africa Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 172. Middle East & Africa Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 173. Middle East & Africa Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Digital Diabetes Management Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 177. Saudi Arabia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 178. Saudi Arabia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 179. Saudi Arabia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 180. Saudi Arabia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 183. UAE Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 184. UAE Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 185. UAE Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 186. UAE Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
Figure 189. South Africa Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
Figure 190. South Africa Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
Figure 191. South Africa Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
Figure 192. South Africa Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
Figure 193. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Device Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Patient Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What is the market size and growth rate of the global digital diabetes management market?
What are the major factors influencing the growth of the global digital diabetes management market?
Who are the key players operating in the global digital diabetes management market?
What regions are covered in the final report of the global digital diabetes management market?
See Related Reports
India Fish Farming Market Assessment, Opportunities and Forecast, 2017-2031F
India fish farming market is projected to witness a CAGR of 5.40% during the forecast period FY2025-FY2032, growing from USD 21.48 billion in FY2024 to USD 32.71 billion in FY2032. ....Read More
Published on
September 2024
3,300
India Mobile Crusher and Screener Market Assessment, Opportunities and Forecast, 2017-2031F
India mobile crusher and screener market is projected to witness a CAGR of 5.30% during the forecast period FY2025-FY2032, growing from USD 235.48 million in FY2024 to USD 355.94 million in FY2032.....Read More
Published on
September 2024
3,300
India Generic Drugs Market Assessment, Opportunities and Forecast, 2017-2031F
India generic drugs market is projected to witness a CAGR of 8.29% during the forecast period FY2025-FY2032, growing from USD 13.71 billion in FY2024 to USD 25.94 billion in FY2032.....Read More
Published on
September 2024
3,300
Japan Generic Drugs Market Assessment, Opportunities and Forecast, 2017-2031F
Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD 12.72 billion in FY2024 to USD 23.23 billion in FY2032. ....Read More
Published on
September 2024
3,300
Purchase Options
USD ($)
i
2,760
3,000
8%
i
4,050
4,500
10%
i
5,016
5,700
12%
i
6,970
8,200
15%
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
